参考文献/References:
[1]Linde C,Abraham WT,Gold MR,et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms[J]. J Am Coll Cardiol,2008,52(23):1834‐1843.
[2]Linde C,Gold MR,Abraham WT,et al. Long-term impact of cardiac resynchronization therapy in mild heart failure:5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study[J].Eur Heart J,2013,34(33):2592‐2599.
[3]St John Sutton M,Ghio S,Plappert T,et al. Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association classⅠ/Ⅱheart failure[J]. Circulation,2009,120(19):1858‐1865.
[4]Bank AJ,Rischall A,Gage RM,et al. Comparison of cardiac resynchronization therapy outcomes in patients with New York Heart Association functional classⅠ/ⅡversusⅢ/Ⅳheart failure[J]. J Card Fail,2012,18(5):373‐378.
[5]Byrne MJ,Helm RH,Daya S,et al. Diminished left ventricular dyssynchrony and impact of resynchronization in failing hearts with right versus left bundle branch block[J]. J Am Coll Cardiol,2007,50(15):1484‐1490.
[6]Wokhlu A,Rea RF,Asirvatham SJ,et al. Upgrade and de novo cardiac resynchronization therapy:impact of paced or intrinsic QRS morphology on outcomes and survival[J]. Heart Rhythm,2009,6(10):1439‐1447.
[7]Stockburger M,Moss AJ,Klein HU,et al. Sustained clinical benefit of cardiac resynchronization therapy in non-LBBB patients with prolonged PR-interval:MADIT-CRT long-term follow-up[J]. Clin Res Cardiol,2016,105(11):944‐952.
[8]Pastore G,Morani G,Maines M,et al. Patients with right bundle branch block and concomitant delayed left ventricular activation respond to cardiac resynchronization therapy[J]. Europace,2018,20(11):e171‐e178.
[9]Kawata H,Bao H,Curtis JP,et al. Cardiac resynchronization defibrillator therapy for nonspecific intraventricular conduction delay versus right bundle branch block[J].J Am Coll Cardiol,2019,73(24):3082‐3099.
[10]Sengupta PP,Tajik AJ,Chandrasekaran K,et al. Twist mechanics of the left ventricle:principles and application[J]. JACC Cardiovasc Imaging,2008,1(3):366‐376.
[11]Achilli A,Sassara M,Ficili S,et al. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and "narrow" QRS[J]. J Am Coll Cardiol,2003,42(12):2117‐2124.
[12]Bleeker GB,Holman ER,Steendijk P,et al. Cardiac resynchronization therapy in patients with a narrow QRS complex[J]. J Am Coll Cardiol,2006,48(11):2243‐2250.
[13]Ruschitzka F,Abraham WT,Singh JP,et al. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex[J]. N Engl J Med,2013,369(15):1395‐1405.
[14]Wang G,Zhao Z,Zhao S,et al. Effect of cardiac resynchronization therapy on patients with heart failure and narrow QRS complexes:a meta-analysis of five randomized controlled trials[J]. J Interv Card Electrophysiol,2015,44(1):71‐79.
[15]Varma N,Sogaard P,Bax JJ,et al. Interaction of left ventricular size and sex on outcome of cardiac resynchronization therapy among patients with a narrow QRS duration in the EchoCRT trial [J].J Am Heart Assoc,2018,7(11):e009592.
[16]Delnoy PP,Ottervanger JP,Luttikhuis HO,et al. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure[J]. Am J Cardiol,2007,99(9):1252‐1257.
[17]Upadhyay GA,Choudhry NK,Auricchio A,et al. Cardiac resynchronization in patients with atrial fibrillation:a meta-analysis of prospective cohort studies[J]. J Am Coll Cardiol,2008,52(15):1239‐1246.
[18]Brignole M,Pokushalov E,Pentimalli F,et al. A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS[J]. Eur Heart J,2018,39(45):3999‐4008.
[19]Khazanie P,Greiner MA,Al-Khatib SM,et al. Comparative effectiveness of cardiac resynchronization therapy among patients with heart failure and atrial fibrillation:findings from the National Cardiovascular Data Registry’s Implantable Cardioverter-Defibrillator Registry[J]. Circ Heart Fail,2016,9(6):10.1161/CIRCHEARTFAILURE.115.002324 e002324..
[20]St John Sutton M,Plappert T,Adamson PB,et al. Left ventricular reverse remodeling with biventricular versus right ventricular pacing in patients with atrioventricular block and heart failure in the BLOCK HF trial[J]. Circ Heart Fail,2015,8(3):510‐518.
[21]Curtis AB,Worley SJ,Chung ES et al. Improvement in clinical outcomes with biventricular versus right ventricular pacing:the BLOCK HF study[J]. J Am Coll Cardiol,2016,67(18):2148‐2157
[22]Funck RC,Mueller HH,Lunati M,et al. Characteristics of a large sample of candidates for permanent ventricular pacing included in the Biventricular Pacing for Atrio-ventricular Block to Prevent Cardiac Desynchronization Study (BioPace)[J]. Europace,2014,16(3):354‐362.
[23]Kolek MJ,Dresen WF,Wells QS et al. Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patients[J]. Pacing Clin Electrophysiol,2013,36(3):354‐361.
[24]Leclercq C,Burri H,Curnis A,et al. Cardiac resynchronization therapy non-responder to responder conversion rate in the more response to cardiac resynchronization therapy with MultiPoint Pacing (MORE-CRT MPP) study:results from PhaseⅠ[J]. Eur Heart J,2019,40(35):2979‐2987.
[25]Schiedat F,Sch?ne D,Aweimer A,et al. Multipoint left ventricular pacing with large anatomical separation improves reverse remodeling and response to cardiac resynchronization therapy in responders and non-responders to conventional biventricular pacing[J]. Clin Res Cardiol,2020,109(2):183‐193.
[26]胡威,苏芳菊,张卫泽.左室四极导线在心脏再同步化治疗中的应用进展[J]. 心血管病学进展,2020,(3):268-271.
[27]Barra S,Providência R,Duehmke R,et al. Cause-of-death analysis in patients with cardiac resynchronization therapy with or without a defibrillator:a systematic review and proportional meta-analysis[J]. Europace,2018,20(3):481-491.
[28]Sharma PS,Dandamudi G,Herweg B,et al. Permanent His-bundle pacing as an alternative to biventricular pacing for cardiac resynchronization therapy:a multicenter experience[J]. Heart Rhythm,2018,15(3):413‐420.
[29]Wu S,Su L,Vijayaraman P,et al. Left bundle branch pacing for cardiac resynchronization therapy:non-randomized on treatment comparison with His bundle pacing and biventricular pacing [J]. Can J Cardiol,2020,S0828-282X(20)30439-6.
相似文献/References:
[1]丁娟,刘地川.心力衰竭与线粒体功能障碍的研究进展[J].心血管病学进展,2016,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
DING Juan,LIU Dichuan.Research Progress of Heart Failure and Mitochondrial Dysfunction[J].Advances in Cardiovascular Diseases,2016,(12):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
[2]罗秀林,综述,张烁,等.肾动脉去交感神经术治疗心力衰竭——希望还是炒作[J].心血管病学进展,2016,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
LUO Xiulin,ZHANG Shuo.Renal Sympathetic Denervation for Heart Failure—Hopes or Hypes[J].Advances in Cardiovascular Diseases,2016,(12):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
[3]查凤艳,综述,覃数,等.心源性恶病质发病机制的研究进展[J].心血管病学进展,2016,(3):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
ZHA Fengyan,QIN Shu.Advances in Pathogenesis of Cardiac Cachexia[J].Advances in Cardiovascular Diseases,2016,(12):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
[4]李慧,综述,齐国先,等.老年射血分数保留的心功能不全研究进展[J].心血管病学进展,2016,(4):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
LI Hui,QI Guoxian.Research Progress of Heart Failure with Preserved Ejection Fraction in Elderly People[J].Advances in Cardiovascular Diseases,2016,(12):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
[5]亢玉,综述,张庆,等.二尖瓣瓣叶在功能性二尖瓣反流发生机制中的角色[J].心血管病学进展,2016,(4):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
KANG Yu,ZHANG Qing.Role of Mitral Leaflets in Pathogenesis of Functional Mitral Regurgitation[J].Advances in Cardiovascular Diseases,2016,(12):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
[6]史秀莉,张庆,喻鹏铭.心力衰竭患者运动训练方式及其疗效的研究进展[J].心血管病学进展,2015,(5):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
SHI Xiuli,ZHANG Qing,YU Pengming.Exercise Training Modalities and Their Treatment Effects on
Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2015,(12):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
[7]黄晓凤 熊峰.超声心动图技术在优化心脏再同步化治疗效果中的应用[J].心血管病学进展,2019,(7):1043.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.020]
HUANG XiaofengXIONG Feng.Application of Echocardiography in Optimizing Cardiac Resynchronization Therapy[J].Advances in Cardiovascular Diseases,2019,(12):1043.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.020]
[8]熊卓超,陈康玉,严激.无创血流动力学评价在心力衰竭中的应用进展[J].心血管病学进展,2019,(6):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
XIONG Zhuochao,CHEN Kangyu,YAN Ji.Application Progress of Noninvasive Hemodynamic Evaluation in Heart Failure[J].Advances in Cardiovascular Diseases,2019,(12):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
[9]高薇 陈伟.铁过载性心肌病[J].心血管病学进展,2019,(5):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
GAO WeiCHEN Wei.Iron Overload Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(12):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
[10]何燕 刘育.C型利钠肽与心力衰竭[J].心血管病学进展,2019,(5):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
HE Yan,LIU Yu.C-type Natriuretic Peptide and Heart Failure[J].Advances in Cardiovascular Diseases,2019,(12):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
[11]陈益帆 周秀娟.希氏束起搏在心力衰竭患者中的临床应用进展[J].心血管病学进展,2021,(1):64.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
CHEN Yifan,ZHOU Xiujuan.Clinical Application of His Bundle Pacing in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2021,(12):64.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
[12]汪汉 蔡琳邓晓奇 李锦 童琳 刘汉雄.双心室起搏模式下心力衰竭患者的心脏研究[J].心血管病学进展,2022,(4):380.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.022]
WANG Han,CAI lin,DENG Xiaoqi,et al.Cardiac Electromechanical Coupling in Patients with Heart Failure under Biventricular Pacing Mode[J].Advances in Cardiovascular Diseases,2022,(12):380.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.022]
[13]陈铳铳 周秀娟.左束支起搏治疗心力衰竭的研究进展[J].心血管病学进展,2022,(2):137.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.011]
CHEN Chongchong,ZHOU Xiujuan.Left Bundle Branch Pacing in the Treatment of Heart Failure[J].Advances in Cardiovascular Diseases,2022,(12):137.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.011]
[14]汪汉 蔡琳 邓晓奇 李锦 童琳 刘汉雄.双心室起搏对心力衰竭患者心脏电机械同步性的影响[J].心血管病学进展,2022,(9):860.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.020]
WANG Han,CAI Lin,DENG Xiaoqi,et al.Effect of Biventricular Pacing on Cardiac Electromechanical Synchronization in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2022,(12):860.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.020]
[15]万小倩 孙磊 顾翔.如何提高心脏再同步化治疗反应性[J].心血管病学进展,2023,(6):486.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.002]
WAN XiaoqianSUN LeiGU Xiang.How to Improve the Response of the Cardiac Resynchronization Therapy[J].Advances in Cardiovascular Diseases,2023,(12):486.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.002]
[16]李佳霖 李常青于海波 梁延春.心脏再同步化治疗方法应用现状与进展[J].心血管病学进展,2023,(12):1065.[doi:10.16806/j.cnki.issn.1004-3934.2023.12.003]
LI Jialin,LI Changqing,YU Haibo,et al.Current Status and Progress of Cardiac Resynchronization Therapy[J].Advances in Cardiovascular Diseases,2023,(12):1065.[doi:10.16806/j.cnki.issn.1004-3934.2023.12.003]